CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Gift President and CEO gave 1,460 shares (gift)
- 4 Open-market sale Chief Financial Officer sold 1,750 shares at $105.47 ($184,573)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $104.79 ($1,571,850)
- 4 Open-market sale Director sold 24,000 shares at $105.00 ($2,520,000)
- 4 Open-market sale Chief Financial Officer sold 24,765 shares at $104.24 ($2,581,504)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 54,700 shares at $101.00 ($5,524,700)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 3 of 36 · 707 filings